You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

CLINICAL TRIALS PROFILE FOR CARVEDILOL PHOSPHATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for CARVEDILOL PHOSPHATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00123903 ↗ COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria Terminated GlaxoSmithKline Phase 3 2005-07-01 This study was designed to determine whether COREG MR is more effective than TOPROL-XL in reducing microalbuminuria in type 2 diabetic or non-diabetic patients with high blood pressure and microalbuminuria.
NCT00273052 ↗ COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension Completed GlaxoSmithKline Phase 3 2006-01-05 This study was designed to determine whether treatment with COREG MR is more effective at maintaining a better lipid profile than treatment with TOPROL-XL for hypertension.
NCT00323037 ↗ A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure Completed CTI Clinical Trial and Consulting Services Phase 3 2006-03-01 The purpose of this study is to determine if Coreg CR is as effective as Coreg IR in improving heart function in subjects with stable chronic heart failure.
NCT00323037 ↗ A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure Completed GlaxoSmithKline Phase 3 2006-03-01 The purpose of this study is to determine if Coreg CR is as effective as Coreg IR in improving heart function in subjects with stable chronic heart failure.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for CARVEDILOL PHOSPHATE

Condition Name

Condition Name for CARVEDILOL PHOSPHATE
Intervention Trials
Congestive Heart Failure 1
Heart Failure, Congestive 1
Heart Failure, Congestive and Microalbuminuria 1
Hypertension 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for CARVEDILOL PHOSPHATE
Intervention Trials
Heart Failure 3
Hypertension 2
Prehypertension 1
Cardiovascular Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for CARVEDILOL PHOSPHATE

Trials by Country

Trials by Country for CARVEDILOL PHOSPHATE
Location Trials
United States 87
Canada 12
Puerto Rico 2
Japan 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for CARVEDILOL PHOSPHATE
Location Trials
Minnesota 3
Virginia 3
Texas 3
South Carolina 3
Pennsylvania 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for CARVEDILOL PHOSPHATE

Clinical Trial Phase

Clinical Trial Phase for CARVEDILOL PHOSPHATE
Clinical Trial Phase Trials
Phase 3 3
Phase 1/Phase 2 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for CARVEDILOL PHOSPHATE
Clinical Trial Phase Trials
Completed 4
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CARVEDILOL PHOSPHATE

Sponsor Name

Sponsor Name for CARVEDILOL PHOSPHATE
Sponsor Trials
GlaxoSmithKline 5
CTI Clinical Trial and Consulting Services 1
CTI-1, LLC 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for CARVEDILOL PHOSPHATE
Sponsor Trials
Industry 6
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.